One-stage ridge splitting in the upper jaw using piezo surgery or a bone-disc technique

Evaluation of Endosseous Implants in One Stage Ridge Splitting Using the Conventional Technique Versus the Use of Piezo Surgery in the Maxilla

NA · Cairo University · NCT06891261

We will try two ridge-splitting techniques—piezo surgery and bone discs—to widen narrow upper-jaw bone in adults needing a single-tooth implant.

Quick facts

PhaseNA
Study typeInterventional
Enrollment20 (estimated)
Ages20 Years to 48 Years
SexAll
SponsorCairo University (other)
Drugs / interventionschemotherapy
Locations1 site (Cairo)
Trial IDNCT06891261 on ClinicalTrials.gov

What this trial studies

Participants are randomized to one-stage ridge splitting in the maxilla performed either with piezoelectric bone inserts or with a bone-disc osteotomy, followed by bone chisels, drills, expanders and implant placement. All participants receive baseline CBCT, diagnostic wax-up and stent fabrication, and repeat CBCT at four months to document bone changes. Procedures are performed under local infiltration anesthesia with a full-thickness mucoperiosteal pyramidal flap and periosteal releasing incisions for tension-free closure. The protocol measures ridge width gain and implant site readiness after four months.

Who should consider this trial

Good fit: Adults with a single missing upper tooth, maxillary residual bone height of at least 8 mm and ridge width between 3–5 mm who can undergo CBCT imaging and attend follow-up visits.

Not a fit: Patients who smoke heavily, have uncontrolled metabolic or bone disease, recent head/neck radiotherapy or chemotherapy, pregnancy, active local bone pathology, or who are uncooperative are unlikely to benefit.

Why it matters

Potential benefit: If successful, the preferred technique could widen the alveolar ridge with less bone trauma and improve conditions for stable implant placement.

How similar studies have performed: Piezo-assisted ridge splitting has reported favorable outcomes in several case series and some clinical trials, while the bone-disc approach has less extensive published evidence.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with maxilla residual alveolar bone height not less than 8 mm.
* Alveolar bone width from 5mm to 3mm.
* Both genders.
* At least single missing tooth.
* Previous failed implants.
* Tapered or cylinder cross sectioned alveolar bone defect pattern.

Exclusion Criteria:

* Heavy smokers more than 20 cigarettes per day.
* Patients with bone disease that may affect normal healing, example; hyperparathyroidism.
* Patients had radiotherapy and chemotherapy in head and neck.
* Patients had neoplasms in sites to be grafted.
* Patients with Metabolic diseases uncontrolled diabetic patients, Glycated hemoglobin (Hb A1c) more than 7 mg\\dl.
* Pregnant females.
* Patients with Para functional habits, apprehensive and non-cooperative.
* Bone pathology related to the site to be grafted.
* Psychological problems, stress situation (socially or professionally), emotional instability, and unrealistic patients' expectations.
* Intraoral soft and hard tissue pathology.
* Systemic condition that contraindicates implant placement.
* Under the age of 18 years.
* Hourglass defects or defects with bone concavities and or undercuts.

Where this trial is running

Cairo

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Ridge Augmentation, Bone Augmentation, ridge augmentation, One stage ridge splitting in maxilla., Piezo Surgery

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.